Due to C/EBPα′s critical role in the differentiation-proliferation axis and its chronic inhibition in FLT3-mutated AML, there is a strong rationale to target C/EBPα and upregulate its expression to reduce the uncontrolled growth of AML cells. The gene discussed is CEBPA; the disease is acute myeloid leukemia.